沙库巴曲缬沙坦-话题@MedSci

#沙库巴曲缬沙坦#

12篇内容 | 767人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1616568, encodeId=106f161656820, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=Cardiovasc Diabetol：沙库巴曲缬沙坦钠片对糖尿病合并心力衰竭患者血糖的影响, objectType=article, longId=735928, objectId=063ee3592845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=063ee3592845, replyNumber=0, likeNumber=41, createdTime=2022-08-17, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=063ee3592845, moduleTitle=Cardiovasc Diabetol：沙库巴曲缬沙坦钠片对糖尿病合并心力衰竭患者血糖的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=063ee3592845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616567, encodeId=bf0e161656ef6, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=ACC重磅：新心衰指南再次强调"四联 "疗法，沙库巴曲缬沙坦或为首选！, objectType=article, longId=723714, objectId=304ee2371471, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=304ee2371471, replyNumber=0, likeNumber=55, createdTime=2022-04-08, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=304ee2371471, moduleTitle=ACC重磅：新心衰指南再次强调"四联 "疗法，沙库巴曲缬沙坦或为首选！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=304ee2371471)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616566, encodeId=a68b1616566ed, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=J Clin Hypertens：沙库巴曲缬沙坦ARNI治疗亚洲人群难治性高血压结果发布, objectType=article, longId=301099, objectId=19ad30109965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ad30109965, replyNumber=0, likeNumber=36, createdTime=2022-03-20, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ad30109965, moduleTitle=J Clin Hypertens：沙库巴曲缬沙坦ARNI治疗亚洲人群难治性高血压结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19ad30109965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616565, encodeId=2bca1616565af, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=JAMA子刊：新药沙库巴曲缬沙坦治疗晚期HFrEF患者有效性不足, objectType=article, longId=294141, objectId=4aff29414108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4aff29414108, replyNumber=0, likeNumber=43, createdTime=2022-01-19, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4aff29414108, moduleTitle=JAMA子刊：新药沙库巴曲缬沙坦治疗晚期HFrEF患者有效性不足, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4aff29414108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616564, encodeId=a13c161656434, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=Circulation | 不懂就问：沙库巴曲缬沙坦 vs 雷米普利对心衰治疗的效果, objectType=article, longId=220914, objectId=c61f22091464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61f22091464, replyNumber=0, likeNumber=33, createdTime=2021-11-25, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61f22091464, moduleTitle=Circulation | 不懂就问：沙库巴曲缬沙坦 vs 雷米普利对心衰治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c61f22091464)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616563, encodeId=53af161656385, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=JAMA：沙库巴曲缬沙坦钠对轻度心力衰竭患者实验室指标及运动能力的影响, objectType=article, longId=220532, objectId=638022053232, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=638022053232, replyNumber=0, likeNumber=46, createdTime=2021-11-19, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=638022053232, moduleTitle=JAMA：沙库巴曲缬沙坦钠对轻度心力衰竭患者实验室指标及运动能力的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=638022053232)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616562, encodeId=0e9516165629f, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=Eur Heart J：沙库巴曲缬沙坦可降低HFpEF患者的明显顽固性高血压, objectType=article, longId=215968, objectId=868121596818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=868121596818, replyNumber=0, likeNumber=39, createdTime=2021-08-20, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=868121596818, moduleTitle=Eur Heart J：沙库巴曲缬沙坦可降低HFpEF患者的明显顽固性高血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=868121596818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616561, encodeId=5b8716165613e, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=J Am Coll Cardiol：沙库巴曲缬沙坦治疗射血分数保留型患者的更佳收缩压应控制在多少, objectType=article, longId=207799, objectId=582b20e79945, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=582b20e79945, replyNumber=0, likeNumber=43, createdTime=2021-03-03, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=582b20e79945, moduleTitle=J Am Coll Cardiol：沙库巴曲缬沙坦治疗射血分数保留型患者的更佳收缩压应控制在多少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=582b20e79945)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616560, encodeId=8db7161656000, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=NEJM：沙库巴曲缬沙坦对低射血分数为45%以上心力衰竭患者的影响, objectType=article, longId=181910, objectId=261f181910b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=261f181910b2, replyNumber=0, likeNumber=40, createdTime=2019-10-26, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=261f181910b2, moduleTitle=NEJM：沙库巴曲缬沙坦对低射血分数为45%以上心力衰竭患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=261f181910b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616559, encodeId=46fa1616559e1, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, objectType=article, longId=141968, objectId=8ab4141968fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab4141968fd, replyNumber=0, likeNumber=32, createdTime=2018-07-01, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab4141968fd, moduleTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab4141968fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616558, encodeId=4ed9161655861, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=ACC 2018：ARNI研究速递：沙库巴曲缬沙坦可能有助于改善心肌功能, objectType=article, longId=132745, objectId=4d6f132e45af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d6f132e45af, replyNumber=0, likeNumber=50, createdTime=2018-03-19, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d6f132e45af, moduleTitle=ACC 2018：ARNI研究速递：沙库巴曲缬沙坦可能有助于改善心肌功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d6f132e45af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1616557, encodeId=4253161655e68, content=<a href='/topic/show?id=afc4644e0f0' target=_blank style='color:#2F92EE;'>#沙库巴曲缬沙坦#</a>, objectTitle=诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生, objectType=article, longId=113448, objectId=2ab3113448b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ab3113448b8, replyNumber=0, likeNumber=43, createdTime=2017-09-22, rootId=0, userName=12498bd5m22暂无昵称, userId=205e19772291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ab3113448b8, moduleTitle=诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ab3113448b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

沙库巴曲缬沙坦

2020-05-29

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

Cardiovasc Diabetol：沙库巴曲缬沙坦钠片对糖尿病合并心力衰竭患者血糖的影响

2022-08-17

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

ACC重磅：新心衰指南再次强调"四联 "疗法，沙库巴曲缬沙坦或为首选！

2022-04-08

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

J Clin Hypertens：沙库巴曲缬沙坦ARNI治疗亚洲人群难治性高血压结果发布

2022-03-20

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

JAMA子刊：新药沙库巴曲缬沙坦治疗晚期HFrEF患者有效性不足

2022-01-19

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

Circulation | 不懂就问：沙库巴曲缬沙坦 vs 雷米普利对心衰治疗的效果

2021-11-25

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

JAMA：沙库巴曲缬沙坦钠对轻度心力衰竭患者实验室指标及运动能力的影响

2021-11-19

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

Eur Heart J：沙库巴曲缬沙坦可降低HFpEF患者的明显顽固性高血压

2021-08-20

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

J Am Coll Cardiol：沙库巴曲缬沙坦治疗射血分数保留型患者的更佳收缩压应控制在多少

2021-03-03

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

NEJM：沙库巴曲缬沙坦对低射血分数为45%以上心力衰竭患者的影响

2019-10-26

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？

2018-07-01

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

ACC 2018：ARNI研究速递：沙库巴曲缬沙坦可能有助于改善心肌功能

2018-03-19

12498bd5m22暂无昵称 (审核中...)

前往app查看评论内容

#沙库巴曲缬沙坦#

诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生

2017-09-22

科室
- - 订阅+
  - 更多科室
工具
服务